Norges Bank Portfolio holdings
Norges Bank, established in 1816 and headquartered in Oslo, Norway, serves as the central bank of Norway, responsible for monetary policy, issuing the Norwegian krone, and maintaining financial stability. Beyond its traditional central banking role, it oversees the management of the Government Pension Fund Global (often called the Norwegian Oil Fund), one of the world’s largest sovereign wealth funds, valued at over $1 trillion, which invests Norway’s oil and gas revenues in global equities, bonds, and real estate. The fund’s investment arm, Norges Bank Investment Management (NBIM), operates independently to ensure long-term wealth preservation for future generations, emphasizing sustainable and ethical investing practices. With its dual role, Norges Bank uniquely blends central banking duties with stewardship of a massive global investment portfolio.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$864M |
| 2 |
T-Mobile US
TMUS
|
+$580M |
| 3 |
Meta Platforms (Facebook)
META
|
+$367M |
| 4 |
AbbVie
ABBV
|
+$348M |
| 5 |
Blackrock
BLK
|
+$335M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$692M |
| 2 |
RTN
Raytheon Company
RTN
|
+$368M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$279M |
| 4 |
Visa
V
|
+$237M |
| 5 |
Intel
INTC
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.84% |
| 2 | Healthcare | 13.58% |
| 3 | Financials | 13.55% |
| 4 | Consumer Discretionary | 13.35% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WUBA
701
DELISTED
58.com Inc
WUBA
| $62.9M | 0.02% |
1,166,622
| – | – |
|
|
SMAR
702
DELISTED
Smartsheet Inc.
SMAR
| $62.9M | 0.02% |
1,235,038
| – | – |
|
|
AXON
703
Axon Enterprise
AXON
$46.4B
| $62.8M | 0.02% |
639,790
+15,521
| +2% | +$1.25M |
|
|
FOLD
704
DELISTED
Amicus Therapeutics
FOLD
| $62.5M | 0.02% |
4,147,749
+550,279
| +15% | +$6.71M |
|
705
Acadia Pharmaceuticals
ACAD
$4.39B
| $62.3M | 0.02% |
1,286,187
-55,317
| -4% | -$2.66M |
|
706
Zai Lab
ZLAB
$2.05B
| $62M | 0.02% |
755,054
-28,734
| -4% | -$1.94M |
|
707
MKS Inc
MKSI
$20.9B
| $62M | 0.02% |
547,367
-25,355
| -4% | -$2.52M |
|
708
Toro Company
TTC
$9.06B
| $61.9M | 0.02% |
932,994
-76,584
| -8% | -$5.03M |
|
|
PLAN
709
DELISTED
Anaplan, Inc.
PLAN
| $61.7M | 0.02% |
1,362,605
+605,154
| +80% | +$25.3M |
|
|
GRA
710
DELISTED
W.R. Grace & Co.
GRA
| $61.6M | 0.02% |
1,212,181
-518,425
| -30% | -$24.6M |
|
711
HEICO Corp Class A
HEI.A
$36.6B
| $61.6M | 0.02% |
757,816
-37,000
| -5% | -$2.87M |
|
712
Delta Air Lines
DAL
$60.2B
| $61.5M | 0.02% |
2,193,060
-45,971
| -2% | -$1.17M |
|
713
Dropbox
DBX
$7.71B
| $61.5M | 0.02% |
2,822,850
+921,834
| +48% | +$19.5M |
|
714
Zions Bancorporation
ZION
$10.3B
| $61.2M | 0.02% |
1,801,001
+155,485
| +9% | +$4.92M |
|
715
Woodward
WWD
$21.5B
| $60.9M | 0.02% |
784,887
+111,054
| +16% | +$7.26M |
|
716
Newell Brands
NWL
$2.71B
| $60.6M | 0.02% |
3,819,118
-266,005
| -7% | -$3.65M |
|
717
PG&E
PCG
$38.4B
| $60.6M | 0.02% |
6,836,167
+1,775,363
| +35% | +$19.3M |
|
|
DOC
718
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $60.6M | 0.02% |
3,459,722
+69,061
| +2% | +$1.13M |
|
719
Sensata Technologies
ST
$6.81B
| $60.6M | 0.02% |
1,626,880
| – | – |
|
720
WIX.com
WIX
$2.38B
| $60.5M | 0.02% |
236,026
-161,547
| -41% | -$28.6M |
|
|
CZR
721
DELISTED
Caesars Entertainment Corporation
CZR
| $60.5M | 0.02% |
4,983,871
+73,540
| +1% | +$743K |
|
722
New York Times
NYT
$12.2B
| $60.4M | 0.02% |
1,437,369
+186,481
| +15% | +$6.78M |
|
723
HF Sinclair
DINO
$15.8B
| $60.3M | 0.02% |
2,065,982
+223,895
| +12% | +$6.65M |
|
724
Nutanix
NTNX
$16.5B
| $60.2M | 0.02% |
2,539,021
+630,314
| +33% | +$13.1M |
|
725
Allogene Therapeutics
ALLO
$635M
| $60M | 0.02% |
1,402,031
+357,198
| +34% | +$12.9M |
|
Similar funds
Norges Bank's Q2 2020 Portfolio in Review
As of Q2 2020, Norges Bank held 2,120 positions worth $347B, up 24% from $281B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Norges Bank's Q2 2020 filing shows 74 new, 993 increased, 738 reduced and 44 closed positions. Its largest new stake was Nikola Corporation Common Stock: 333,333 shares worth $675M. The largest sale was Allergan plc, an estimated $692M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Norges Bank's largest Q2 2020 buy was Nikola Corporation Common Stock: 333,333 shares worth $675M.
- Norges Bank added most to Walmart Inc in Q2 2020, an estimated $864M increase.
- Norges Bank's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $279M.
- Norges Bank fully exited Allergan plc in Q2 2020, selling an estimated $692M.
- Norges Bank's ten largest holdings make up 22% of its $347B portfolio in Q2 2020.
- Norges Bank opened 74 new positions and closed 44 in Q2 2020.
- Norges Bank's portfolio value rose 24% quarter-over-quarter to $347B.
Based on Norges Bank's 13F filing for Q2 2020, filed 7 Aug 2020.